AR and ovarian endometrioid adenocarcinoma: This data is supported by two recent studies: one using the TCGA RNA-sequencing data, demonstrated that low AR expression was associated with shorter overall survival [65] in high-grade serous ovarian carcinoma while the other using immunohistochemical staining in 118 serous and endometrioid ovarian cancers reported that high level of AR was correlated with improved 5-year progression-free and overall survival [24].